Stereotactic Radiosurgery for Lung Lesions

  • Harun Badakhshi


Early-stage non-small cell lung cancer represents still an important problem in thoracic oncology because it causes cancer mortality despite the early-stage status. Oligometastases of solid tumors to the lung might lead to severe functional affections and, and in some cases, to fatal organ failure in patients (f/m) with lung lesions.

Invasive surgical procedures like lobectomy performed openly or minimally invasive seem to be the historic “standard.” Any “standard” has to prove its superiority in terms of safety and effectiveness for patients (f/m), and it is true in the frame of cost efficiency too.

Image-guided stereotactic radiosurgery with its multiple labels like stereotactic ablative radiotherapy (SABR) or stereotactic body radiotherapy (SBRT) could affect lung lesions by deactivating tumor cells. Early-stage non-small cell lung cancer is responsive to high-dose radiotherapy. Metastases, limited by volume, number, and occurrence site, react to radiation by stopping their growth. The aim would be the deactivation of lesions or, at least, to prolong the time free of pulmonary symptoms and, therefore, to have a better quality of life.

Consecutively, it demonstrates a noninvasive high-precision and safe technique in treating patients (f/m).


Stereotactic Body Radiation Therapy Stereotactic Radiosurgery Thoracic Oncology Stereotactic Ablative Radiotherapy Curative Doctrine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Abreu CE, Ferreira PP, de Moraes FY, Neves Jr WF, Gadia R, Carvalho HA. Stereotactic body radiotherapy in lung cancer: an update. J Bras Pneumol. 2015;41(4):376–87.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Altorki NK. Stereotactic body radiation therapy versus wedge resection for medically inoperable stage I lung cancer: tailored therapy or one size fits all? J Clin Oncol. 2010;28(6):905–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Aoki M, Hatayama Y, Kawaguchi H, Hirose K, Sato M, Akimoto H, et al. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study. J Radiat Res. 2015.Google Scholar
  4. 4.
    Aragon J, Perez I, Gonzalez-Rivas D. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. J Thorac Dis. 2015;7(7):1074–5.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Baschnagel AM, Mangona VS, Robertson JM, Welsh RJ, Kestin LL, Grills IS. Lung metastases treated with image-guided stereotactic body radiation therapy. Clin Oncol. 2013;25(4):236–41.CrossRefGoogle Scholar
  6. 6.
    Murray L, Ramasamy S, Lilley J, Snee M, Clarke K, Musunuru HB, et al. Stereotactic ablative radiotherapy (SABR) in patients with medically inoperable peripheral early stage lung cancer: outcomes for the first UK SABR cohort. Clin Oncol. 2016;28(1):4–12.CrossRefGoogle Scholar
  7. 7.
    Green A, Hauge J, Iachina M, Jakobsen E. The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registrydagger. Eur J Cardiothorac Surg. 2016;49(2):589–94.PubMedCrossRefGoogle Scholar
  8. 8.
    Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 2015;121(14):2341–9.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Yoshitake T, Nakamura K, Shioyama Y, Sasaki T, Ohga S, Shinoto M, et al. Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience. Int J Clin Oncol. 2015;20(1):53–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Siva S, Senan S, Ball D. Ablative therapies for lung metastases: a need to acknowledge the efficacy and toxicity of stereotactic ablative body radiotherapy. Ann Oncol. 2015;26(10):2196.PubMedCrossRefGoogle Scholar
  11. 11.
    Naef AP. The mid-century revolution in thoracic and cardiovascular surgery: part 1. Interact Cardiovasc Thorac Surg. 2003;2(3):219–26.PubMedCrossRefGoogle Scholar
  12. 12.
    Naef AP. The mid-century revolution in thoracic and cardiovascular surgery: part 2: Prelude to 20th century cardio-thoracic surgery. Interact Cardiovasc Thorac Surg. 2003;2(4):431–49.PubMedCrossRefGoogle Scholar
  13. 13.
    Churchill ED, Sweet RH, Soutter L, Scannell JG. The surgical management of carcinoma of the lung; a study of the cases treated at the Massachusetts General Hospital from 1930 to 1950. J Thorac Surg. 1950;20(3):349–65.PubMedGoogle Scholar
  14. 14.
    Lewis RJ, Caccavale RJ, Sisler GE, Mackenzie JW. Video-assisted thoracic surgical resection of malignant lung tumors. J Thorac Cardiovasc Surg. 1992;104(6):1679–85. discussion 85–7.PubMedGoogle Scholar
  15. 15.
    Zhang Z, Zhang Y, Feng H, Yao Z, Teng J, Wei D, et al. Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis. Eur J Cardiothorac Surg. 2013;44(3):407–14.PubMedCrossRefGoogle Scholar
  16. 16.
    Kirby TJ, Mack MJ, Landreneau RJ, Rice TW. Lobectomy – video-assisted thoracic surgery versus muscle-sparing thoracotomy. A randomized trial. J Thorac Cardiovasc Surg. 1995;109(5):997–1001; discussion −2.PubMedCrossRefGoogle Scholar
  17. 17.
    Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy reduces cytokine production more than conventional open lobectomy. Jpn J Thorac Cardiovasc Surg. 2000;48(3):161–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Cai YX, Fu XN, Xu QZ, Sun W, Zhang N. Thoracoscopic lobectomy versus open lobectomy in stage I non-small cell lung cancer: a meta-analysis. PLoS One. 2013;8(12), e82366.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Taioli E, Lee DS, Lesser M, Flores R. Long-term survival in video-assisted thoracoscopic lobectomy vs open lobectomy in lung-cancer patients: a meta-analysis. Eur J Cardiothorac Surg. 2013;44(4):591–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Chen FF, Zhang D, Wang YL, Xiong B. Video-assisted thoracoscopic surgery lobectomy versus open lobectomy in patients with clinical stage non-small cell lung cancer: a meta-analysis. Eur J Surg Oncol. 2013;39(9):957–63.PubMedCrossRefGoogle Scholar
  21. 21.
    Brooks P. Robotic-assisted thoracic surgery for early-stage lung cancer: a review. AORN J. 2015;102(1):40–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Park BJ, Melfi F, Mussi A, Maisonneuve P, Spaggiari L, Da Silva RK, et al. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results. J Thorac Cardiovasc Surg. 2012;143(2):383–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Veronesi G. Robotic lobectomy and segmentectomy for lung cancer: results and operating technique. J Thorac Dis. 2015;7 Suppl 2:S122–30.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Veronesi G, Agoglia BG, Melfi F, Maisonneuve P, Bertolotti R, Bianchi PP, et al. Experience with robotic lobectomy for lung cancer. Innovations. 2011;6(6):355–60.PubMedGoogle Scholar
  25. 25.
    Veronesi G, Galetta D, Maisonneuve P, Melfi F, Schmid RA, Borri A, et al. Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg. 2010;140(1):19–25.PubMedCrossRefGoogle Scholar
  26. 26.
    Ye X, Xie L, Chen G, Tang JM, Ben XS. Robotic thoracic surgery versus video-assisted thoracic surgery for lung cancer: a meta-analysis. Interact Cardiovasc Thorac Surg. 2015;21(4):409–14.PubMedCrossRefGoogle Scholar
  27. 27.
    Rocco G, Martin-Ucar A, Passera E. Uniportal VATS wedge pulmonary resections. Ann Thorac Surg. 2004;77(2):726–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Jutley RS, Khalil MW, Rocco G. Uniportal vs standard three-port VATS technique for spontaneous pneumothorax: comparison of post-operative pain and residual paraesthesia. Eur J Cardiothorac Surg. 2005;28(1):43–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Rocco G. VATS lung biopsy: the uniportal technique. Multi Manual Cardiothorac Surg. 2005;2005(121):mmcts 2004 000356.Google Scholar
  30. 30.
    Rocco G. Endoscopic VATS sympathectomy: the uniportal technique. Multi Manual Cardiothorac Surg. 2005;2005(104):MMCTS 2004 000323.Google Scholar
  31. 31.
    Rocco G, Khalil M, Jutley R. Uniportal video-assisted thoracoscopic surgery wedge lung biopsy in the diagnosis of interstitial lung diseases. J Thorac Cardiovasc Surg. 2005;129(4):947–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Rocco G, Martucci N, Setola S, Franco R. Uniportal video-assisted thoracic resection of a solitary fibrous tumor of the pleura. Ann Thorac Surg. 2012;94(2):661–2.PubMedCrossRefGoogle Scholar
  33. 33.
    Bertolaccini L, Rocco G, Viti A, Terzi A. Geometrical characteristics of uniportal VATS. J Thorac Dis. 2013;5 Suppl 3:S214–6.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Rocco G. History and indications of uniportal pulmonary wedge resections. J Thorac Dis. 2013;5 Suppl 3:S212–3.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Rocco G. VATS and Uniportal VATS: a glimpse into the future. J Thorac Dis. 2013;5 Suppl 3:S174.Google Scholar
  36. 36.
    Ng CS, Rocco G, Wong RH, Lau RW, Yu SC, Yim AP. Uniportal and single-incision video-assisted thoracic surgery: the state of the art. Interact Cardiovasc Thorac Surg. 2014;19(4):661–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Ng CS, Gonzalez-Rivas D, D’Amico TA, Rocco G. Uniportal VATS-a new era in lung cancer surgery. J Thorac Dis. 2015;7(8):1489–91.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Gonzalez-Rivas D, Delgado M, Fieira E, Mendez L, Fernandez R, de la Torre M. Uniportal video-assisted thoracoscopic pneumonectomy. J Thorac Dis. 2013;5 Suppl 3:S246–52.PubMedCentralPubMedGoogle Scholar
  39. 39.
    Gonzalez-Rivas D. VATS lobectomy: surgical evolution from conventional VATS to uniportal approach. ScientificWorldJ. 2012;2012:780842.CrossRefGoogle Scholar
  40. 40.
    Gonzalez-Rivas D, Fieira E, Delgado M, Mendez L, Fernandez R, de la Torre M. Is uniportal thoracoscopic surgery a feasible approach for advanced stages of non-small cell lung cancer? J Thorac Dis. 2014;6(6):641–8.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Gonzalez-Rivas D, Fieira E, Delgado M, de la Torre M, Mendez L, Fernandez R. Uniportal video-assisted thoracoscopic sleeve lobectomy and other complex resections. J Thorac Dis. 2014;6 Suppl 6:S674–81.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Gonzalez-Rivas D, Fieira E, de la Torre M, Delgado M. Bronchovascular right upper lobe reconstruction by uniportal video-assisted thoracoscopic surgery. J Thorac Dis. 2014;6(6):861–3.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Gonzalez-Rivas D, Delgado M, Fieira E, Pato O. Left lower sleeve lobectomy by uniportal video-assisted thoracoscopic approach. Interact Cardiovasc Thorac Surg. 2014;18(2):237–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Ismail M, Helmig M, Swierzy M, Neudecker J, Badakhshi H, Gonzalez-Rivas D, et al. Uniportal VATS: the first German experience. J Thorac Dis. 2014;6 Suppl 6:S650–5.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Paine CH, Ash DV. Interstitial brachytherapy: past-present-future. Int J Radiat Oncol Biol Phys. 1991;21(6):1479–83.PubMedCrossRefGoogle Scholar
  46. 46.
    Thomadsen BR, Williamson JF, Rivard MJ, Meigooni AS. Anniversary paper: past and current issues, and trends in brachytherapy physics. Med Phys. 2008;35(10):4708–23.PubMedCrossRefGoogle Scholar
  47. 47.
    Hannoun-Levi JM, Peiffert D. Brachytherapy in France: past, present and what future? Cancer Radiother. 2013;17(2):73–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Holm HH. The history of interstitial brachytherapy of prostatic cancer. Semin Surg Oncol. 1997;13(6):431–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Ottolenghi F. History of radiotherapy of dermatoses. Rass Dermatol Sifilogr. 1954;7(6):371–94.PubMedGoogle Scholar
  50. 50.
    Gauss CJ. History of gynecological radiotherapy; unscientific recollections of its beginning and development. Strahlentherapie. 1956;100(4):633–48.PubMedGoogle Scholar
  51. 51.
    Lederman M, Wybar K, Busby E. Malignant epibulbar melanoma: natural history and treatment by radiotherapy. Br J Ophthalmol. 1984;68(9):605–17.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Lederman M. The early history of radiotherapy: 1895–1939. Int J Radiat Oncol Biol Phys. 1981;7(5):639–48.PubMedCrossRefGoogle Scholar
  53. 53.
    Lederman M. Panel discussion: the historical development of laryngectomy. VI. History of radiotherapy in the treatment of cancer of the larynx, 1896–1939. Laryngoscope. 1975;85(2):333–53.PubMedCrossRefGoogle Scholar
  54. 54.
    Henk JM. A brief history of British radiotherapy. Int J Radiat Oncol Biol Phys. 1996;36(1):213–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Umegaki Y. History of radiotherapy. Gan No Rinsho Japan J Cancer Clin. 1987;Spec No:1–8.Google Scholar
  56. 56.
    Bilge N. History of radiotherapy in Turkey. Int J Radiat Oncol Biol Phys. 1996;35(5):1069–72.PubMedCrossRefGoogle Scholar
  57. 57.
    Piemonte M. History of radiotherapy in Italy. Radiol Med. 1989;78(5):417–29.PubMedGoogle Scholar
  58. 58.
    Thibault M. History of radiotherapy at the Hotel-Dieu de Quebec. Vie Med Can Fr. 1973;2(10):955–6.PubMedGoogle Scholar
  59. 59.
    Levendag PC, Vermey J, Senan S. The history of radiotherapy in The Netherlands. Int J Radiat Oncol Biol Phys. 1996;35(3):615–22.PubMedCrossRefGoogle Scholar
  60. 60.
    Okawa T. Development of radiotherapy – history and future prospects. Gan To Kagaku Ryoho. 1999;26(9):1269–74.PubMedGoogle Scholar
  61. 61.
    Okawa T. History of radiotherapy for cancer. Gan To Kagaku Ryoho Cancer Chemotherapy. 1999;26 Suppl 1:15–22.Google Scholar
  62. 62.
    Novak D. The early history of radiotherapy. Hist Sci Med. 1982;17(Spec 2):262–4.Google Scholar
  63. 63.
    Ohkawa T. The history of radiotherapy of breast cancer. Rinsho hoshasen Clin Radiography. 1989;34(4):455–61.Google Scholar
  64. 64.
    Fletcher GH. Regaud lecture perspectives on the history of radiotherapy. Radiother Oncol. 1988;12(4):iii–v, 253–71.Google Scholar
  65. 65.
    Badakhshi H. On cancer, a biopic. Part 1. On cancer. HB++ ed. Berlin: HB++; 2016. p. 25 Minutes.Google Scholar
  66. 66.
    Rockwell S. Experimental radiotherapy: a brief history. Radiat Res. 1998;150(5 Suppl):S157–69.PubMedCrossRefGoogle Scholar
  67. 67.
    Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.CrossRefPubMedGoogle Scholar
  68. 68.
    Ricardi U, Badellino S, Filippi AR. Stereotactic body radiotherapy for early stage lung cancer: history and updated role. Lung Cancer. 2015;90(3):388–96.PubMedCrossRefGoogle Scholar
  69. 69.
    Zwitter M. Dutch statistics on lung cancer: sobering experience for a new approach. J Thorac Oncol. 2012;7(2):269–71.PubMedCrossRefGoogle Scholar
  70. 70.
    Lasak JM, Gorecki JP. The history of stereotactic radiosurgery and radiotherapy. Otolaryngol Clin North Am. 2009;42(4):593–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Senan S, Lagerwaard F. Stereotactic radiotherapy for stage I lung cancer: current results and new developments. Cancer Radiother. 2010;14(2):115–8.PubMedCrossRefGoogle Scholar
  72. 72.
    Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest. 2003;124(5):1946–55.PubMedCrossRefGoogle Scholar
  73. 73.
    Fritz P, Kraus HJ, Muhlnickel W, Hammer U, Dolken W, Engel-Riedel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol. 2006;1:30.PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16(6):630–7.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Chang JY, Bezjak A, Mornex F. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. J Thorac Oncol. 2015;10(4):577–85.PubMedCrossRefGoogle Scholar
  76. 76.
    Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol. 2010;94(1):1–11.PubMedCrossRefGoogle Scholar
  77. 77.
    Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol. 2006;45(7):779–86.PubMedCrossRefGoogle Scholar
  78. 78.
    Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Marino K, et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer. 2004;45(1):45–55.PubMedCrossRefGoogle Scholar
  80. 80.
    Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys. 2004;60(1):186–96.PubMedCrossRefGoogle Scholar
  81. 81.
    Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2(7 Suppl 3):S94–100.PubMedCrossRefGoogle Scholar
  82. 82.
    Lagerwaard FJ, Haasbeek CJ, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70(3):685–92.PubMedCrossRefGoogle Scholar
  83. 83.
    Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S. Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol. 2011;6(7):1221–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Dahele M, Senan S. The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms. Cancer Research and Treatment. 2011;43(2):75–82.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Hurkmans CW, van Lieshout M, Schuring D, van Heumen MJ, Cuijpers JP, Lagerwaard FJ, et al. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study). Int J Radiat Oncol Biol Phys. 2011;80(3):918–27.PubMedCrossRefGoogle Scholar
  86. 86.
    Palma D, Senan S. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Curr Opin Oncol. 2011;23(2):133–9.PubMedCrossRefGoogle Scholar
  87. 87.
    Lagerwaard FJ, Aaronson NK, Gundy CM, Haasbeek CJ, Slotman BJ, Senan S. Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer. J Thorac Oncol. 2012;7(7):1148–54.PubMedCrossRefGoogle Scholar
  88. 88.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):348–53.PubMedCrossRefGoogle Scholar
  89. 89.
    Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012;82(3):1149–56.PubMedCrossRefGoogle Scholar
  90. 90.
    Palma DA, Senan S. Early-stage non-small cell lung cancer in elderly patients: should stereotactic radiation therapy be the standard of care? Int J Radiat Oncol Biol Phys. 2012;84(5):1058–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis. Lancet Oncol. 2012;13(8):802–9.PubMedCrossRefGoogle Scholar
  92. 92.
    Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes. Acta Oncol. 2013;52(5):910–8.PubMedCrossRefGoogle Scholar
  93. 93.
    Palma DA, Senan S. Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy. Clin Lung Cancer. 2013;14(1):1–5.PubMedCrossRefGoogle Scholar
  94. 94.
    Senan S. Surgery versus stereotactic radiotherapy for patients with early-stage non-small cell lung cancer: more data from observational studies and growing clinical equipoise. Cancer. 2013;119(15):2668–70.PubMedCrossRefGoogle Scholar
  95. 95.
    Senan S, Paul MA, Lagerwaard FJ. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol. 2013;14(7):e270–4.PubMedCrossRefGoogle Scholar
  96. 96.
    Senthi S, Dahele M, van de Ven PM, Slotman BJ, Senan S. Late radiologic changes after stereotactic ablative radiotherapy for early stage lung cancer: a comparison of fixed-beam versus arc delivery techniques. Radiother Oncol. 2013;109(1):77–81.PubMedCrossRefGoogle Scholar
  97. 97.
    Senthi S. Use of stereotactic body radiation therapy with salvage surgery to improve outcomes for early stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;148(4):1760.PubMedCrossRefGoogle Scholar
  98. 98.
    Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys. 2010;77(4):1146–50.PubMedCrossRefGoogle Scholar
  99. 99.
    Buyyounouski MK, Balter P, Lewis B, D’Ambrosio DJ, Dilling TJ, Miller RC, et al. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010;78(1):3–10.PubMedCrossRefGoogle Scholar
  100. 100.
    Tajima Y, Nakayama H, Itonaga T, Shiraishi S, Okubo M, Mikami R, et al. Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer. Br J Radiol. 2015;88(1052):20150122.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Takeshita J, Masago K, Kato R, Otsuka K, Okuda C, Hata A, et al. A new strategy for metachronous primary lung cancer: stereotactic body radiation therapy with concurrent chemotherapy. Anticancer Res. 2015;35(5):3103–7.PubMedGoogle Scholar
  102. 102.
    Tariq I, Humbert-Vidan L, Chen T, South CP, Ezhil V, Kirkby NF, et al. Mathematical modelling of tumour volume dynamics in response to stereotactic ablative radiotherapy for non-small cell lung cancer. Phys Med Biol. 2015;60(9):3695–713.PubMedCrossRefGoogle Scholar
  103. 103.
    Woody NM, Stephans KL, Marwaha G, Djemil T, Videtic GM. Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: safety and efficacy. Int J Radiat Oncol Biol Phys. 2015;92(2):325–31.PubMedCrossRefGoogle Scholar
  104. 104.
    Ricardi U, Badellino S, Filippi AR. Stereotactic radiotherapy for early stage non-small cell lung cancer. Radiation oncology journal. 2015;33(2):57–65.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Louie AV, Palma DA, Dahele M, Rodrigues GB, Senan S. Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons. Radiother Oncol. 2015;114(2):138–47.PubMedCrossRefGoogle Scholar
  106. 106.
    Liu HW, Gabos Z, Ghosh S, Roberts B, Lau H, Kerba M. Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta – a population-based study. Radiother Oncol. 2015;117(1):71–6.PubMedCrossRefGoogle Scholar
  107. 107.
    Lievens Y, Obyn C, Mertens AS, Van Halewyck D, Hulstaert F. Stereotactic body radiotherapy for lung cancer: how much does it really cost? J Thorac Oncol. 2015;10(3):454–61.PubMedCrossRefGoogle Scholar
  108. 108.
    Kelley KD, Benninghoff DL, Stein JS, Li JZ, Byrnes RT, Potters L, et al. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy. Radiat Oncol. 2015;10:120.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Hayashi S, Tanaka H, Hoshi H. Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: evaluation of mass-like fibrosis. Thoracic cancer. 2015;6(2):186–93.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    He J, Huang Y, Shi S, Hu Y, Zeng Z. Comparison of effects between central and peripheral stage I lung cancer using image-guided stereotactic body radiotherapy via helical tomotherapy. Technol Cancer Res Treat. 2015.Google Scholar
  111. 111.
    Chehade S, Palma DA. Stereotactic radiotherapy for early lung cancer: evidence-based approach and future directions. Reports of Practical Oncology and Radiotherapy. 2015;20(6):403–10.PubMedCrossRefGoogle Scholar
  112. 112.
    Mehta M, Noyes W, Craig B, Lamond J, Auchter R, French M, et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys. 1997;39(2):445–54.PubMedCrossRefGoogle Scholar
  113. 113.
    Luparia A, Durando M, Campanino P, Regini E, Lucarelli D, Talenti A, et al. Efficacy and cost-effectiveness of stereotactic vacuum-assisted core biopsy of nonpalpable breast lesions: analysis of 602 biopsies performed over 5 years. Radiol Med. 2011;116(3):477–88.PubMedCrossRefGoogle Scholar
  114. 114.
    Sakanaka K, Mizowaki T, Arakawa Y, Araki N, Oya N, Takahashi JA, et al. Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience. Int J Clin Oncol. 2011;16(1):27–32.PubMedCrossRefGoogle Scholar
  115. 115.
    Sher DJ, Wee JO, Punglia RS. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2011;81(5):e767–74.PubMedCrossRefGoogle Scholar
  116. 116.
    Gupta M, Babaiah M, Dinesh Kumar M, Hirapara PH, Patidar AK, Walke RV. Comparative dosimetric evaluation of three-dimensional conformal and stereotactic radiotherapy for treatment of intracranial tumors. J Egypt Natl Canc Inst. 2012;24(4):169–73.PubMedCrossRefGoogle Scholar
  117. 117.
    Hodges JC, Lotan Y, Boike TP, Benton R, Barrier A, Timmerman RD. Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer. J Oncol Pract. 2012;8(3 Suppl):e31s–7s.Google Scholar
  118. 118.
    Varghese TK. Comparative effectiveness issues in lung cancer. Cancer Treat Res. 2015;164:101–19.PubMedCrossRefGoogle Scholar
  119. 119.
    Smith BD, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, et al. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. Journal of geriatric oncology. 2015;6(4):324–31.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Sher DJ, Fidler MJ, Liptay MJ, Koshy M. Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer. Lung Cancer. 2015;88(3):267–74.PubMedCrossRefGoogle Scholar
  121. 121.
    Sher DJ, Fidler MJ, Seder CW, Liptay MJ, Koshy M. Relationship between radiation therapy dose and outcome in patients treated with neoadjuvant chemoradiation therapy and surgery for stage IIIA non-small cell lung cancer: a population-based, comparative effectiveness analysis. Int J Radiat Oncol Biol Phys. 2015;92(2):307–16.PubMedCrossRefGoogle Scholar
  122. 122.
    Smith BD, Jiang J, Chang JY, Welsh J, Likhacheva A, Buchholz TA, et al. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. J Geriatr Oncol. 2015.Google Scholar
  123. 123.
    Crabtree TD, Denlinger CE, Meyers BF, El Naqa I, Zoole J, Krupnick AS, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010;140(2):377–86.PubMedCrossRefGoogle Scholar
  124. 124.
    Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28(6):928–35.PubMedCrossRefGoogle Scholar
  125. 125.
    Timmerman RD. Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who’s down for the count? J Clin Oncol. 2010;28(6):907–9.PubMedCrossRefGoogle Scholar
  126. 126.
    Filippi AR, Franco P, Ricardi U. Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer? Reports of Practical Oncology and Radiotherapy. 2014;19(4):275–9.PubMedCrossRefGoogle Scholar
  127. 127.
    Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, et al. Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol. 2014;190(1):26–33.PubMedCrossRefGoogle Scholar
  128. 128.
    Metzger U, Uhlschmid G, Largiader F. Current state of surgery in the treatment of lung metastases. Schweiz Med Wochenschr. 1981;111(36):1303–6.PubMedGoogle Scholar
  129. 129.
    Girard P, Ducreux M, Baldeyrou P, Rougier P, Le Chevalier T, Bougaran J, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol. 1996;14(7):2047–53.PubMedGoogle Scholar
  130. 130.
    Presicci PF, Veronesi G, D’Aiuto M, Spaggiari L. Long-term survival after salvage surgery for colorectal lung metastases. Ann Thorac Surg. 2005;79(1):325–6.PubMedCrossRefGoogle Scholar
  131. 131.
    Hou Z, Zhang H, Gui L, Wang W, Zhao S. Video-assisted thoracoscopic surgery versus open resection of lung metastases from colorectal cancer. International journal of clinical and experimental medicine. 2015;8(8):13571–7.PubMedPubMedCentralGoogle Scholar
  132. 132.
    Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37–49.PubMedCrossRefGoogle Scholar
  133. 133.
    Pastorino U. Lung metastasectomy: why, when, how. Crit Rev Oncol Hematol. 1997;26(3):137–45.PubMedCrossRefGoogle Scholar
  134. 134.
    Pastorino U. Lung metastasectomy for colorectal cancer. Tumori. 1997;83(1 Suppl):S28–30.PubMedGoogle Scholar
  135. 135.
    Aurello P, Petrucciani N, Giulitti D, Campanella L, D’Angelo F, Ramacciato G. Pulmonary metastases from gastric cancer: Is there any indication for lung metastasectomy? A systematic review. Med Oncol. 2016;33(1):9.PubMedCrossRefGoogle Scholar
  136. 136.
    Treasure T, Mineo T, Ambrogi V, Fiorentino F. Survival is higher after repeat lung metastasectomy than after a first metastasectomy: too good to be true? J Thorac Cardiovasc Surg. 2015;149(5):1249–52.PubMedCrossRefGoogle Scholar
  137. 137.
    Treasure T, Macbeth F. Doubt about effectiveness of lung metastasectomy for sarcoma. J Thorac Cardiovasc Surg. 2015;149(1):93–4.PubMedCrossRefGoogle Scholar
  138. 138.
    Mineo TC, Ambrogi V. Lung metastasectomy: an experience-based therapeutic option. Annals of translational medicine. 2015;3(14):194.PubMedPubMedCentralGoogle Scholar
  139. 139.
    Gonzalez M, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis. Future Oncol. 2015;11(2 Suppl):31–3.PubMedCrossRefGoogle Scholar
  140. 140.
    Giuliano K, Sachs T, Montgomery E, Guzzetta A, Brock M, Pawlik TM, et al. Survival following lung metastasectomy in soft tissue sarcomas. Thorac Cardiovasc Surg. 2015.Google Scholar
  141. 141.
    Tonnies M, Pfannschmidt J, Bauer TT, Kollmeier J, Tonnies S, Kaiser D. Metastasectomy for synchronous solitary non-small cell lung cancer metastases. Ann Thorac Surg. 2014;98(1):249–56.PubMedCrossRefGoogle Scholar
  142. 142.
    Renaud S, Falcoz PE, Alifano M, Olland A, Magdeleinat P, Pages O, et al. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience. J Surg Oncol. 2014;109(8):823–9.PubMedCrossRefGoogle Scholar
  143. 143.
    Gonzalez M, Robert JH, Halkic N, Mentha G, Roth A, Perneger T, et al. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg. 2012;36(2):386–91.PubMedCrossRefGoogle Scholar
  144. 144.
    Corona-Cruz JF, Dominguez-Parra LM, Saavedra-Perez D, Jimenez-Fuentes E, Villarreal-Garza C, Green-Schneeweis L, et al. Lung metastasectomy: long-term outcomes in an 18-year cohort from a single center. Surg Oncol. 2012;21(3):237–44.PubMedCrossRefGoogle Scholar
  145. 145.
    Venuta F, Rolle A, Anile M, Martucci N, Bis B, Rocco G. Techniques used in lung metastasectomy. J Thorac Oncol. 2010;5(6 Suppl 2):S145–50.PubMedCrossRefGoogle Scholar
  146. 146.
    Van Raemdonck D, Friedel G. The European Society of Thoracic Surgeons lung metastasectomy project. J Thorac Oncol. 2010;5(6 Suppl 2):S127–9.PubMedCrossRefGoogle Scholar
  147. 147.
    Primrose J, Treasure T, Fiorentino F. Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life? Respirology. 2010;15(5):742–6.PubMedCrossRefGoogle Scholar
  148. 148.
    Friedel G, Pastorino U, Ginsberg RJ, Goldstraw P, Johnston M, Pass H, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg. 2002;22(3):335–44.PubMedCrossRefGoogle Scholar
  149. 149.
    Koong HN, Pastorino U, Ginsberg RJ. Is there a role for pneumonectomy in pulmonary metastases? International Registry of Lung Metastases. Ann Thorac Surg. 1999;68(6):2039–43.PubMedCrossRefGoogle Scholar
  150. 150.
    Friedel G, Pastorino U, Buyse M, Ginsberg RJ, Girard P, Goldstraw P, et al. Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases – the International Registry of Lung Metastases. Zentralbl Chir. 1999;124(2):96–103.PubMedGoogle Scholar
  151. 151.
    Treasure T, Macbeth F. The GILDA trial finds no survival benefit from intensified screening after primary resection of colorectal cancer: the PulMiCC trial tests the survival benefit of pulmonary metastasectomy for detected asymptomatic lung metastases. Ann Oncol. 2015.Google Scholar
  152. 152.
    Treasure T. Lung metastasectomy paradoxes in practice: reflections on the Catania conference. Future Oncol. 2015;11(2 Suppl):1–3.PubMedCrossRefGoogle Scholar
  153. 153.
    Cardillo G, Mokhles S, Williams N, Macbeth F, Russell C, Treasure T. Comment on: ‘KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.’ Variation in survival associated with proto-oncogenes is not evidence for effectiveness of lung metastasectomy. Br J Cancer. 2015;113(11):1636.Google Scholar
  154. 154.
    Treasure T, Brew-Graves C, Fallowfield L, Farewell V, Golesworthy T, Leonard P, et al. The need to determine whether lung metastasectomy improves survival in advanced colorectal cancer. BMJ. 2014;348:g4085.PubMedCrossRefGoogle Scholar
  155. 155.
    Jegatheeswaran S, Satyadas T, Sheen AJ, Treasure T, Siriwardena AK. Thoracic surgical management of colorectal lung metastases: a questionnaire survey of members of the Society for Cardiothoracic Surgery in Great Britain and Ireland. Ann R Coll Surg Engl. 2013;95(2):140–3.PubMedPubMedCentralCrossRefGoogle Scholar
  156. 156.
    Treasure T. Surgery for lung metastases from colorectal cancer: the practice examined. Expert Rev Respir Med. 2007;1(3):335–41.PubMedGoogle Scholar
  157. 157.
    Morikawa T, Takeuchi K, Fujino H, Fukumura M, Kimura M, Furuie H, et al. Stereotactic radiosurgery with the gamma knife for brain metastases in patients with lung cancer. Nihon Kyobu Shikkan Gakkai Zasshi. 1995;33(1):44–50.PubMedGoogle Scholar
  158. 158.
    Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, et al. Stereotactic Body Radiation Therapy (SBRT) for lung metastases. Acta Oncol. 2006;45(7):808–17.PubMedCrossRefGoogle Scholar
  159. 159.
    Hof H, Hoess A, Oetzel D, Debus J, Herfarth K. Stereotactic single-dose radiotherapy of lung metastases. Strahlenther Onkol. 2007;183(12):673–8.PubMedCrossRefGoogle Scholar
  160. 160.
    Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol. 2009;27(10):1579–84.PubMedCrossRefGoogle Scholar
  161. 161.
    Filippi AR, Badellino S, Guarneri A, Levis M, Botticella A, Mantovani C, et al. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Technol Cancer Res Treat. 2014;13(1):37–45.PubMedGoogle Scholar
  162. 162.
    Filippi AR, Badellino S, Ceccarelli M, Guarneri A, Franco P, Monagheddu C, et al. Stereotactic ablative radiation therapy as first local therapy for lung oligometastases from colorectal cancer: a single-institution cohort study. Int J Radiat Oncol Biol Phys. 2015;91(3):524–9.PubMedCrossRefGoogle Scholar
  163. 163.
    Siva S, Callahan JW, Kron T, Chesson B, Barnett SA, Macmanus MP, et al. Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases. Acta Oncol. 2015;54(8):1105–12.PubMedCrossRefGoogle Scholar
  164. 164.
    Wang Z, Kong QT, Li J, Wu XH, Li B, Shen ZT, et al. Clinical outcomes of cyberknife stereotactic radiosurgery for lung metastases. J Thorac Dis. 2015;7(3):407–12.PubMedPubMedCentralGoogle Scholar
  165. 165.
    Aoki M, Hatayama Y, Kawaguchi H, Hirose K, Sato M, Akimoto H, et al. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study. J Radiat Res. 2016;57(1):55–61.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Harun Badakhshi
    • 1
  1. 1.Department of Radiation OncologyCharité School of MedicineBerlinGermany

Personalised recommendations